Dr. Millikan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 E 3RD ST ESSENTIA HEALTH DULUTH CLINIC
Duluth, MN 55805Phone+1 218-786-3625
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1988 - 1991
- University of Miami Leonard M. Miller School of MedicineClass of 1988
Certifications & Licensure
- IL State Medical License 2022 - 2026
- MN State Medical License 2013 - 2024
- WA State Medical License 2020 - 2023
- OR State Medical License 2020 - 2022
- UT State Medical License 2019 - 2022
- TX State Medical License 1994 - 2013
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2008
- America's Top Doctors for Cancer Castle Connolly, 2005-2007
Clinical Trials
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer Start of enrollment: 1996 Aug 01
- Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer Start of enrollment: 1997 Dec 01
- Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium Start of enrollment: 2001 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 208 citationsA Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naive Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chem...David J. McConkey, Woonyoung Choi, Yu Shen, I. Ling Lee, Sima P. Porten
European Urology. 2016-05-01 - 295 citationsPlatinum-Based Chemotherapy for Variant Castrate-Resistant Prostate CancerAna Aparicio, Andrea L. Harzstark, Paul G. Corn, Sijin Wen, John C. Araujo
Clinical Cancer Research. 2013-07-01 - 54 citationsEvaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.Lu Wang, Andrea Rotnitzky, Xihong Lin, Randall E. Millikan, Peter F. Thall
Journal of the American Statistical Association. 2012-07-24
Other
- Experimental systemic therapy of metastatic bladder cancerMillikan RE
http://www.uptodate.com/contents/experimental-systemic-therapy-of-metastatic-bladder-cancer
UpToDate, Wolters Kluwer Health - 2012-09-25
Grant Support
- Neoadjuvant Therapy For Advanced Bladder CancerNational Cancer Institute1996–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: